USA Financial Formulas’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,331
Closed -$1.65M 266
2025
Q2
$1.65M Sell
15,331
-2,606
-15% -$264K 0.28% 31
2025
Q1
$1.81M Buy
17,937
+3,401
+23% +$342K 0.3% 20
2024
Q4
$1.3M Sell
14,536
-2,118
-13% -$186K 0.2% 24
2024
Q3
$1.4M Sell
16,654
-996
-6% -$78.5K 0.22% 34
2024
Q2
$1.36M Buy
17,650
+13,710
+348% +$1M 0.22% 32
2024
Q1
$270K Buy
3,940
+3,867
+5,297% +$249K 0.04% 158
2023
Q4
$4.22K Sell
73
-21,849
-100% -$1.17M ﹤0.01% 265
2023
Q3
$1.16M Buy
21,922
+1,751
+9% +$91.8K 1.73% 9
2023
Q2
$1.09M Sell
20,171
-425
-2% -$22.2K 1.68% 11
2023
Q1
$1.03M Buy
+20,596
New +$971K 1.67% 14
2022
Q3
$5K Buy
129
+68
+111% +$2.73K 0.01% 123
2022
Q2
$2K Hold
61
﹤0.01% 190
2022
Q1
$3K Buy
61
+37
+154% +$1.6K ﹤0.01% 200
2021
Q4
$1K Sell
24
-22
-48% -$924 ﹤0.01% 302
2021
Q3
$2K Buy
46
+22
+92% +$973 ﹤0.01% 307
2021
Q2
$1K Hold
24
﹤0.01% 338
2021
Q1
$1K Hold
24
﹤0.01% 290
2020
Q4
$1K Buy
24
+5
+26% +$180 ﹤0.01% 256
2020
Q3
$1K Hold
19
﹤0.01% 243
2020
Q2
$1K Buy
+19
New +$684 ﹤0.01% 149
2019
Q1
Sell
-91,676
Closed -$3.53M 149
2018
Q4
$3.53M Buy
+91,676
New +$3.32M 0.88% 36

Other funds holding BSX

USA Financial Formulas's BSX Position: Q3 2025 in Review

USA Financial Formulas sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 15,331 shares — an estimated $1.65M sold.

USA Financial Formulas first reported a position in BSX in Q4 2018 and held it in 21 quarters. The position peaked at $3.53M in Q4 2018. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • USA Financial Formulas reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • USA Financial Formulas sold 15,331 Boston Scientific shares in Q3 2025, an estimated $1.65M.
  • USA Financial Formulas first reported a position in Boston Scientific in Q4 2018 and held it in 21 quarters.
  • USA Financial Formulas's Boston Scientific position peaked at $3.53M in Q4 2018.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on USA Financial Formulas's 13F filing for Q3 2025, filed 10 Oct 2025.